With more than 5 million fatalities and close to 300 million reported cases, COVID-19 is the
first documented pandemic due to a coronavirus that continues to be a major health …

Aims GLP-1RA has many beneficial properties, including anti-inflammatory, anti-
obesogenic, pulmonary protective effects as well as beneficial impact on gut microbiome …

Abstract In 2015, the Nobel Committee for Physiology or Medicine, in its only award for
treatments of infectious diseases since six decades prior, honoured the discovery of …

Ivermectin (IVM) is an FDA approved macrocyclic lactone compound traditionally used to
treat parasitic infestations and has shown to have antiviral potential from previous in-vitro …

Background: We provided a comprehensive evaluation of efficacy of available treatments for
coronavirus disease 2019 (COVID-19). Methods: We searched for candidate COVID-19 …

Acute respiratory distress syndrome (ARDS) is an overwhelming inflammatory disorder of
the lung due to direct and indirect insults to the lungs. ARDS is characterized by increased …

Vitamin D has many protective properties and potential role against acute lung injury. Low
serum vitamin D is associated with high risk of pneumonia and development of acute …

Background Currently, JAK-inhibitors are repurposed for therapy of Covid-19 because of
their ability in restraining immune response, yet the corroboration regarding their advantage …

Aim Delirium is a common presenting symptom among older patients. Patients who
presented with delirium may have a higher morbidity and mortality rate due to older age …

Background Ivermectin became a popular choice for COVID-19 treatment among clinicians
and the public following encouraging results from pre-print trials and in vitro studies. Early …